PMC9480580_01
Target lesions at baseline. Target lesions at the vaginal stump and in front of rectum was 44 mm in longest diameter at baseline (red arrow).
OTT-15-973-g0001.jpg
PMC9480580_01_OTT-15-973-g0001.jpg
f0001
At baseline, the diameter of target lesions at the vaginal stump and in front of rectum was 44 mm (Figure 1), and multiple lymph nodes below 8 mm in the internal iliac vessel region were observed for non-target lesions (Figure 2).
Non-target lesions at baseline. Multiple lymph nodes below 8 mm in the internal iliac vessel region were observed for non-target lesions at baseline (red arrow).
OTT-15-973-g0002.jpg
PMC9480580_01_OTT-15-973-g0002.jpg
f0002
At baseline, the diameter of target lesions at the vaginal stump and in front of rectum was 44 mm (Figure 1), and multiple lymph nodes below 8 mm in the internal iliac vessel region were observed for non-target lesions (Figure 2).
Non-target lesions at the end of the 4th cycle. Non-target lesions disappeared at the end of the 4th cycle of treatment and did not recur (red arrow).
OTT-15-973-g0003.jpg
PMC9480580_01_OTT-15-973-g0003.jpg
f0003
After the 4th cycle of treatment, non-target lesions disappeared and did not recur (Figure 3).
Target lesions at the end of the 11th cycle. Target lesions at the vaginal stump and in front of rectum reduced to 3.9 mm in longest diameter at the end of the 11th cycle (red arrow), which sharply decreased by 91.14%.
OTT-15-973-g0004.jpg
PMC9480580_01_OTT-15-973-g0004.jpg
f0004
At the end of the 11th cycle, the diameter of target lesions reduced to 3.9 mm without significant change thereafter (Figure 4).